Verition Fund Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$697K Hold
7,600
﹤0.01% 1557
2026
Q1
$648K Buy
7,600
+4,600
+153% +$410K ﹤0.01% 1494
2025
Q4
$237K Sell
3,000
-48,700
-94% -$3.82M ﹤0.01% 3109
2025
Q3
$4.13M Buy
51,700
+3,000
+6% +$256K 0.02% 1350
2025
Q2
$4.43M Buy
48,700
+26,500
+119% +$2.42M 0.02% 1257
2025
Q1
$2.08M Sell
22,200
-62,300
-74% -$5.58M 0.01% 1548
2024
Q4
$7.68M Sell
84,500
-16,100
-16% -$1.54M 0.03% 650
2024
Q3
$10.4M Hold
100,600
0.05% 386
2024
Q2
$9.76M Buy
100,600
+37,500
+59% +$3.46M 0.05% 360
2024
Q1
$5.68M Buy
63,100
+53,300
+544% +$4.52M 0.04% 588
2023
Q4
$781K Buy
+9,800
New +$737K 0.01% 1292
2022
Q2
Sell
-9,900
Closed -$751K 2434
2022
Q1
$751K Hold
9,900
0.01% 1654
2021
Q4
$845K Buy
+9,900
New +$773K 0.01% 1400

Other funds holding CL

Verition Fund Management's CL Position: Q2 2026 in Review

Verition Fund Management opened a new position in Colgate-Palmolive (CL) in Q2 2026: 55,326 shares worth $5.07M. The stake represents 0.03% of the portfolio and ranks #647 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in CL as recently as Q4 2025.

Verition Fund Management first reported a position in CL in Q2 2013 and has held it in 40 quarters since. The position peaked at $17.9M in Q4 2025. 2,025 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Verition Fund Management held 55,326 shares of Colgate-Palmolive worth $5.07M as of Q2 2026.
  • Colgate-Palmolive was a new Verition Fund Management position in Q2 2026.
  • Colgate-Palmolive made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #647 holding.
  • Verition Fund Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 40 quarters since.
  • Verition Fund Management's Colgate-Palmolive position peaked at $17.9M in Q4 2025.
  • 2,025 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.